Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0R6UV
|
|||
Former ID |
DIB018013
|
|||
Drug Name |
BMS-690514
|
|||
Synonyms |
BMS 690514; BMS690514
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Chronic pain [ICD-11: MG30; ICD-10: R52.1, R52.2; ICD-9: 338.2, 780] | Phase 2 | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C19H24N6O2
|
|||
Canonical SMILES |
COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CCC(C(C4)O)N
|
|||
InChI |
1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1
|
|||
InChIKey |
CSGQVNMSRKWUSH-IAGOWNOFSA-N
|
|||
CAS Number |
CAS 859853-30-8
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
16440760, 23508405, 24419214, 44390420, 56311932, 80481817, 124976959, 126731251, 131549339, 136368033, 136368271, 139411627, 144115737, 152088812, 152258179, 152344096, 160647015, 162011878, 162029688, 163642743, 164042004, 164178266, 174539900, 185997054, 188937099, 198989201, 223366208, 223683351, 227452231, 246525206, 251963024, 251970977, 252154827, 252215017, 252462431
|
References | Top | |||
---|---|---|---|---|
REF 1 | A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. Cancer Res. 2007 Jul 1;67(13):6253-62. | |||
REF 2 | Preclinical pharmacokinetics and in vitro metabolism of BMS-690514, a potent inhibitor of EGFR and VEGFR2. J Pharm Sci. 2010 Aug;99(8):3579-93. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.